ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Capstar Special Purpose Acquisition Corp

Capstar Special Purpose Acquisition Corp (CPSR)

7.36
0.00
(0.00%)
Closed January 26 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
7.36
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
7.36
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CPSR Latest News

Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar

Proceeds from this transaction will be used to further support the national launch of Plenity Gelesis will begin trading on the New York Stock Exchange as “GLS” on Friday, January 14, 2022 and...

Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee

Ms. Bauerlein brings success in scaling to $300M+ revenue in direct-to-consumer business model and public company execution as Gelesis plans to scale Plenity® to meet growing consumer demand with...

Have Your Cake and Eat It Too: Plenity® Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting Assumptions

With the prevalence of fad diets, food shaming and resulting guilt, leading health experts advise against villainizing specific food groups and moving to flexibility and...

Gelesis’ FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer

Plenity® is transforming weight management with a clinically proven approach made from naturally derived building blocks As Chief Nutrition Officer, Bauer will focus on educating healthcare...

Gelesis Receives $30 Million Plenity Order from Ro

Gelesis’ new commercial manufacturing facility is now producing Plenity® at large scale, enabling supply to meet the growing demand Gelesis announced today that leading U.S. direct-to-patient...

Nature’s Scientific Reports Features Gelesis’ Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage

New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to address obesity and gut related conditions by emulating compositional and...

Two Senior Scientific Leaders at Gelesis Awarded Top Industry Honors

Chief Scientific Officer Elaine Chiquette, Pharm.D., Named Among the Top 25 Women Leaders in Biotechnology Elizabeth Pash, MS, RD, LDN, Honored by Academy of Nutrition and Dietetics for...

Gelesis, a Consumer-Focused Biotherapeutics Company & the Maker of Plenity®, to Become a Publicly Traded Company via Merger ...

Building on the successful beta launch of its first product Plenity®, Gelesis aims to transform weight management. Gelesis developed a novel biomimetic therapeutic platform that has yielded...

Capstar Special Purpose Acquisition Corp. Receives Expected Notice from NYSE Regarding Delayed Quarterly Report

Capstar Special Purpose Acquisition Corp. (NYSE:CPSR.U; CPSR; CPSR WS) (the “Company”) today announced that, as expected, on May 25, 2021 it received a notice from the New York Stock Exchange...

Capstar Special Purpose Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering

AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Capstar Special Purpose Acquisition Corp. (the “Company”), today announced the pricing of its initial public offering of 24,000,000 units at a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CPSR - Frequently Asked Questions (FAQ)

What is the current Capstar Special Purpose ... share price?
The current share price of Capstar Special Purpose ... is US$ 7.36
What is the 1 year trading range for Capstar Special Purpose ... share price?
Capstar Special Purpose ... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALURAllurion Technologies Inc
US$ 8.55
(131.08%)
68.16M
FPHFive Point Holdings LLC
US$ 5.7593
(41.85%)
4.28M
DDD3D Systems Corporation
US$ 3.849
(26.61%)
10.68M
BKSYBlackSky Technology Inc
US$ 14.98
(25.46%)
4.22M
SRFMSurf Air Mobility Inc
US$ 4.51
(20.59%)
699.84k
VNCEVince Holding Corp
US$ 3.285
(-15.77%)
2.16M
NUVBPanacea Acquisition Corp
US$ 2.51
(-9.39%)
2.09M
SSTSystem1 Inc
US$ 0.7701
(-8.41%)
326.04k
MOG.BMoog Inc
US$ 197.56
(-7.54%)
774
CFCF Industries Holdings Inc
US$ 88.06
(-7.54%)
4.22M
QBTSD Wave Quantum Inc
US$ 6.095
(1.08%)
139.06M
BBDBanco Bradesco SA
US$ 1.93
(-0.52%)
71.81M
ABEVAmbev SA
US$ 1.80
(-1.10%)
68.72M
ALURAllurion Technologies Inc
US$ 8.55
(131.08%)
68.16M
SESSES AI Corporation
US$ 1.125
(2.27%)
66.22M

Discussion

View Full Feed
Walter4 Walter4 5 minutes ago
https://www.sec.gov/newsroom/press-releases/2022-62
SONGD
oldmystic oldmystic 5 minutes ago
So, I remain long and like INVESTOR I am waiting for proof! I know you don't care for him
Investor is the second smartest guy in the room and I like him. I pay attention to his analysis and appreciate his skepticism.
Doc328 knows a hell of a lot, but his 3-4% is at this point a TOTAL
AVXL
Gmenfan Gmenfan 6 minutes ago
It is addicting.
BBANBOB BBANBOB 6 minutes ago
It was in one of the articles put on the board the other day
RDGL
HoldEm777 HoldEm777 6 minutes ago
Clown show? Ok… You are the entire reason I dug in here to start with…. Now you opened that door again. Game On!!!!
RDAR
Gmenfan Gmenfan 7 minutes ago
Ivermectin, the miracle drug:

I guess it's OK now but not when those heavily invested in the pharmaceutical companies told us likewise!

https://x.com/DrSHankMD/status/1883137922310000727
floridaboy floridaboy 7 minutes ago
Etrade
RECX
awesomed007 awesomed007 7 minutes ago
Two cnbc high profile figures will be there at the microcap conference and would not waste their time if it was not an important event, and noting cnbc does not recognize or cover OTC’s on air, maybe 1 or 2 mentioned a year. Go Telvantis USA!👍
RDAR
zab zab 8 minutes ago
Oh good, did you get your trump trophy. 
Gmenfan Gmenfan 8 minutes ago
So now it's OK now but not when those heavily invested in the pharmaceutical companies told us likewise!
Gmenfan Gmenfan 8 minutes ago
I guess it's OK now but not when those heavily invested in the pharmaceutical companies told us likewise!

Ivermectin, the miracle drug:

https://x.com/DrSHankMD/status/1883137922310000727
getmoreshares getmoreshares 8 minutes ago
https://pbs.twimg.com/media/GiIJIAWWEAEBIgf?format=jpg&name=900x900
getmoreshares getmoreshares 9 minutes ago
https://pbs.twimg.com/media/GiIJIAWWEAEBIgf?format=jpg&name=900x900
BigBang BigBang 10 minutes ago
”and kept his promise on “no tax on tips.”What about his promise of no tax on Social Security benefits for the elderly? This tax on benefits should have never been imposed in the first place. It has always been a case of double taxation!
COOP
StayHumble StayHumble 10 minutes ago
💹1 BILLION+ Historic BUYS💹Lots of Xperts Here💹 https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/historical
HMBL
Gmenfan Gmenfan 10 minutes ago
I'm in the don't care for group. He was OK with CSNY.
Walter4 Walter4 11 minutes ago
https://www.sec.gov/newsroom/press-releases/2022-62
BCAP
Gmenfan Gmenfan 11 minutes ago
Can't blame them:

LA real estate guru reveals No. 1 reason why some wildfire victims won’t return
By Kristen Altus, Fox Business Published Jan. 25, 2025, 8:29 p.m. ET

https://nypost.com/wp-content/uploads/sites/2/2025/01/newspress-collage-2vc83sreb-1737875173141.
Gmenfan Gmenfan 12 minutes ago
Can't blame them:

LA real estate guru reveals No. 1 reason why some wildfire victims won’t return
By Kristen Altus, Fox Business Published Jan. 25, 2025, 8:29 p.m. ET

https://nypost.com/wp-content/uploads/sites/2/2025/01/newspress-collage-2vc83sreb-1737875173141.
HD2001 HD2001 12 minutes ago
What company would want advice from a failed company with a CEO that has lied to shareholders and potential shareholders for years just look at the share price it tells the most truth about xalles. ( Xalles curates innovative companies into its ecosystem. Clients will receive Core Advisory services
XALL
Jack_Bolander Jack_Bolander 13 minutes ago
FACE IT : PLUG is a $2.00 Stock !

PLUG may have traded as high as $75, but PLUG has NEVER been worth $75. This is why PLUG has been in FREE-FALL ever since, and back to where PLUG has languished prior to the baseless Rally.

Until there is a MAJOR POSITIVE CATALYST (an
PLUG
StayHumble StayHumble 13 minutes ago
wow!💹10M+ $HIRU XPERT💹BUYS💹💹💹 https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades
HIRU
kbaz kbaz 14 minutes ago
I don't know what Y'all are talking about with the Cryptic Language. Boards like this are a Cesspool of The Wicked. Only a Few know why there has not been an 8k Submitted in over 6 years... Updating on the BAHA MAR, 7 Paths, Backend Web3 Capability and Now AI..... But the Rumbling Continues
FRZT
fredscott36 fredscott36 14 minutes ago
ONLY.....ONLY possible ENDGAME within a few days, for the UWBI sewer rats................ANY NAOMI FINAL ORDER.......springs the Sonterra settlement, our case, over at the USCA/2...................legal weirdness, but I think all we need is a "DECISION" by Naomi, and then we close out Sonterra......
Investor2014 Investor2014 15 minutes ago
Nice to see OhSay out to save you from those who wants to save you - lol!

A truly admirable poster and perhaps actually the only one here.

Aside from that you should probably listen only to Hoskuld who knows it all and so far only got one trial outcome completely wrong.
AVXL

Your Recent History

Delayed Upgrade Clock